Medlab Clinical Limited (ASX: MDC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medlab Clinical Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medlab Clinical Limited (ASX: MDC)
Latest News
Healthcare Shares
Why is the Medlab (ASX:MDC) share price surging 8% today?
Share Market News
Here's why the Medlab (ASX:MDC) share price is rising today
Share Gainers
Why Clean TeQ, Medlab, Newcrest, & Ramelius are storming higher today
Share Gainers
Why this ASX cannabis share is shooting 15% higher today
Share Gainers
Why THC Global and these ASX cannabis shares are rocketing higher today
52-Week Highs
Why this ASX biotech is printing 52-week highs
Share Gainers
This small-cap ASX biotech's share price is soaring today
Share Gainers
Why Medlab, Metcash, SKY and Space Global, and WiseTech shares charged higher today
Share Market News
These small cap ASX shares are on the rise today
⏸️ Investing
Is Medlab Clinical Ltd the best small cap healthcare buy on the ASX?
⏸️ Investing
Why these pot stocks are moving higher
⏸️ Investing
Why shares of Medlab Clinical Ltd have risen 37% in 2018
1❯
MDC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Matthew John Hudson | Non-Executive Director | Mar 2023 |
Mr Hudson has experience raising capital for projects based in Africa, Latin America, and Asia. He is a former Credit Suisse and Arthur Andersen advisor, who is now the Co-Founder and Managing Director of Hudson Koch Energy, which operates 43 oil and gas wells across Kansas and Oklahoma. He is also the Founder and Managing Director of United Minerals which operated the historic Potosi Mine in Chihuahua, Mexico.
|
| Mr Sean Michael Hall | Chief Executive Officer | Apr 2014 |
Mr Hall has over 20 years of experience in the Australian Healthcare and food industries and early phase drug discovery in Australia and Asia. Sean is best known for building Australia's practitioner brand, BioCeuticals. Dr Hall is a member of Medicines Australia, American Federation for Medical Research, American Academy of Anti-Ageing Medicine, Ausbiotech, a member of the Scientific Advisory Board for BITs Life Science China and a Board Member of the International Probiotics Association.
|
| Mr Tim Walker | Non-Executive Director | Mar 2024 |
Mr Walker is a corporate finance professional with experience in originating, managing, and leading resource-focused transaction. Specialising in M&A transactions across the Canadian and Australian markets, IPOs, and equity and debt financing solutions. Tim's past directorships with exploration companies have provided him with experience across commodity groups, including lithium exploration, rare earth and niobium hosted carbonatite deposits, whilst also having experience transacting on iron ore and base metal projects.
|
| Mr Edmond Tan | Non-Executive Director | Mar 2024 |
Mr Tan is a financial services professional with over 10 years' experience in roles which include Private Wealth Management, Family Office, and Structured Finance. In addition, he was involved in the establishment of a mid-market private equity joint venture fund with a focus on foreign investment into Australia. Currently, Mr Tan is a Director of Regenerate Pty Ltd a rare earth magnet recycling technology based in Houston, Texas. He is also the Australian Representative for Obsidian Global Partners LLC, a structured financier for ASX listed companies.
|
| Mr Kerem Kaya | Chief Financial OfficerCompany Secretary | May 2021 |
-
|
| Kerem Kaya | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr Sean Michael Hall | 389,041 | 17.04% |
| Farjoy Pty Ltd | 205,663 | 9.01% |
| HSBC Custody Nominees (Australia) Limited | 88,229 | 3.86% |
| UBS Nominees Pty Ltd | 85,316 | 3.74% |
| Fit Investments Pty Ltd Hallab Investment A/C | 75,563 | 3.31% |
| Realm Group Pty Limited | 54,705 | 2.40% |
| Citicorp Nominees Pty Limited | 49,798 | 2.18% |
| Mr Drew Anthony Townsend Townsend Family A/C | 37,038 | 1.62% |
| Richard Albarran Albarran Family No 2 A/C | 37,038 | 1.62% |
| United Trolley Collections P/L | 32,970 | 1.44% |
| BNP Paribas Nominees Pty Ltd Ib Au Noms Retailclient | 30,272 | 1.33% |
| Mr Michael Jack Hall & Mrs Elizabeth Ann Jones Hall Jones Super Fund A/C | 29,820 | 1.31% |
| Netwealth Investments Limited Wrap Services A/C | 20,186 | 0.88% |
| Villamagna Inc | 20,000 | 0.88% |
| BNP Paribas Noms Pty Ltd | 17,164 | 0.75% |
| Daniel P Moses (Nominees) Pty Limited Daniel Moses Family A/C | 16,667 | 0.73% |
| Acron Holdings Pty Limited Acron Super Fund A/C | 16,181 | 0.71% |
| Kenney Family Investments Pty Ltd Kenney Family Account | 15,295 | 0.67% |
| Assumo (Nominees) Pty Ltd Assumo S/Fund A/C | 13,334 | 0.58% |
| D J Fairfull Pty Ltd Fairfull Super Fund A/C | 12,651 | 0.55% |
